BAFNAPHARM
BAFNAPHARM · NSE · inactive
3.55
-0.15 (-4.05%)
as of 23 Aug 2019 close
Open
3.70
High
3.85
Low
3.55
Prev close
3.70
52w high
21.85
12 Sept 2018
52w low
3.55
23 Aug 2019
VWAP
3.71
Delivery %
—
n/a
Volume 4,503 · turnover ₹17,000 · NSE bhavcopy (official close) · history since 12 Nov 2012
- Series
- EQ
- F&O
- No
- Status
- Inactive since 02 Apr 2019
Source: NSE equity master · as of 01 Apr 2019
Daily · NSE EOD
Exchange announcements
Source: NSE corporate filings · latest Today 13:28 IST
AllM&AAGM / meetingAnalyst meetBoard meetingBusiness updateManagementComplianceCorporate actionCredit ratingDividendExchange queryGeneral updateInsider / SASTLegalOrder winResults
- 19 Nov 2014 14:51PDF · -Credit rating
Bafna Pharmaceuticals Limited has informed the Exchange that CRISIL has upgraded the Company's rating as CRISIL BB-/stable (Upgraded from CRISIL D) for Long Term rating & CRISIL A4+ (Upgraded from CRISIL D) for Short term Rating in respect of Total bank facilities.
Coming next in news
Arrives in Phase 3. Nothing here is estimated or filled in — we only show data we have.
- Results & board-meeting calendar
- Dividend, split, AGM calendar
- Headlines with source and timestamp
- Two-line factual filing summaries